Febentel Plus combines Fenbendazole 500mg and Ivermectin 25mg — the two most searched antiparasitic cancer protocol drugs in the world in 2026 — into a single pharmaceutical-grade tablet. With 700+ documented cancer cases, an active ICONIC Phase I/II clinical trial, and the 2026 Dr. Makis protocol now guiding thousands of patients globally, this complete guide covers the full protocol tables, 12 Fenbendazole anticancer mechanisms, Ivermectin's PD-L1 immune checkpoint action.